Vaccines in Renal Cell Carcinoma (original) (raw)

Update on vaccine development for renal cell cancer

Open Access Journal of …, 2010

Developing a Rational Tumor Vaccine Therapy for Renal Cell Carcinoma: Immune Yin and Yang

Clinical Cancer Research, 2007

Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study

Birgit Sawitzki

Gene Therapy, 2011

View PDFchevron_right

Translational Mini-Review Series on Vaccines: Dendritic cell-based vaccines in renal cancer

Elena Ranieri

Clinical & Experimental Immunology, 2007

View PDFchevron_right

T Cell-Based Immunotherapy of Metastatic Renal Cell Carcinoma: Modest Success and Future Perspective

Eyad Elkord

Clinical Cancer Research, 2009

View PDFchevron_right

Allogeneic vaccination for renal cell carcinoma: development and monitoring

Bernhard Frankenberger, Dolores Schendel

Bone Marrow Transplantation, 2000

View PDFchevron_right

Short-Term Tumor Cell Lines from Renal Cell Carcinoma for Use as Autologous Tumor Cell Vaccines in the Treatment of Kidney Cancer

Dr. B. Shankar Nayak

Cancer Biotherapy and Radiopharmaceuticals, 2000

View PDFchevron_right

Treatment of Kidney Cancer with Autologous Tumor Cell Vaccines of Short-Term Cell Lines Derived from Renal Cell Carcinoma

Dr. B. Shankar Nayak

Cancer Biotherapy & Radiopharmaceuticals, 2001

View PDFchevron_right

Enhancing the efficacy of cancer vaccines in urologic oncology: new directions

Sergei Kusmartsev

Nature Reviews Urology, 2009

View PDFchevron_right

Exploring immune therapy for renal cancer

Kazuhiro Kakimi

International Journal of Urology, 2011

View PDFchevron_right

Immunotherapy in renal cell cancer: the more the merrier?

sol Maria Narvaez Ruiz

Translational Andrology and Urology, 2012

View PDFchevron_right

Immunotherapeutic strategies for the treatment of renal cell carcinoma: where are we now?

Nahla El-ashmawy

Expert Review of Anticancer Therapy, 2013

View PDFchevron_right

Editorial: Immunotherapy in renal cell carcinoma

Walter Storkus

Frontiers in Oncology

View PDFchevron_right

Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells

Sybille Regn

World Journal of Urology, 2005

View PDFchevron_right

IMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer

Alexandra Kirner

Human vaccines & immunotherapeutics, 2014

View PDFchevron_right

Immunotherapy for Renal Cell Carcinoma

Peter Mulders, Egbert Oosterwijk

European Urology, 2003

View PDFchevron_right

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC

Thomas E Hutson

View PDFchevron_right

A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma

Sybille Regn

Journal of Translational Medicine, 2005

View PDFchevron_right

Immunotherapy of Metastatic Renal Cell Cancer

Mayer Fishman

2002

View PDFchevron_right

Immunotherapy in renal cell carcinoma: latest evidence and clinical implications

Alessia Cimadamore

Drugs in context, 2018

View PDFchevron_right

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial

G Zakrzewski

The Lancet, 2004

View PDFchevron_right

Regulatory T-Cells and Associated Pathways in Metastatic Renal Cell Carcinoma (mRCC) Patients Undergoing DC-Vaccination and Cytokine-Therapy

Jiang Gui

PLoS ONE, 2012

View PDFchevron_right

Role of immunotherapy for renal cell cancer in 2011

Michael Carducci

Journal of the National Comprehensive Cancer Network : JNCCN, 2011

View PDFchevron_right

Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting

Stephan T Kiessig

Cancer Immunology, Immunotherapy, 2010

View PDFchevron_right

Phase II Trial of B7-1 (CD-86) Transduced, Cultured Autologous Tumor Cell Vaccine Plus Subcutaneous Interleukin-2 for Treatment of Stage IV Renal Cell Carcinoma

patricia thompson

Journal of Immunotherapy, 2008

View PDFchevron_right

Immunotherapy in Metastatic Renal Cell Carcinoma: A Comprehensive Review

Rachna Raman

BioMed Research International, 2015

View PDFchevron_right

Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine

Stephan T Kiessig

OncoTargets and Therapy, 2016

View PDFchevron_right

A novel murine model of allogeneic vaccination against renal cancer

marie last

BJU International, 2008

View PDFchevron_right

Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial

Tilman Sauerbruch

Cancer Immunology, Immunotherapy, 2002

View PDFchevron_right

A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings

S. Oudard

Cancer Immunology, Immunotherapy, 2011

View PDFchevron_right

Immunotherapy and gene therapy for renal cell carcinoma

Gabriel Haas

Urologic Oncology: Seminars and Original Investigations, 1997

View PDFchevron_right

Vaccines in Renal Cell Carcinoma (original) (raw)

Related papers